logo
  • ALPAM GROUP
  • Our mission
  • The Alpam team
    • Marcel Denis, JD, LLM, ESQ.
    • Indira Denis, BSN, RN
    • Celestin Odilon, Restaurateur
    • Daniel Dume-Charles, MD
    • Berthony Deslouches, MD, PhD
  • Our work
    • Hurricane Matthew
    • Recovery efforts
    • Volunteering
  • Contact us
  • La Dessalinienne
  • Weekly forum
  • Essay submission
  • SI PA GENYEN SITIRÈ

Berthony Deslouches, MD, PhD

Berthoyn Deslouches, Director
By alpamadmin

Berthony Deslouches

Director

 

 

Berthony Deslouches, MD, PhD, is a Research Assistant Professor at the University of Pittsburg. Berthony holds a Medical Doctor Degree and a Doctorate Degree in Microbiology after completing a ten-year joint Medical Scientist Training Program offered by the University of Pittsburgh School of Medicine and Carnegie Mellon University in 2008. He is a research scientist currently conducting research that focuses on the development of engineered antimicrobial peptides (eCAPs) for applications to hard-to-treat bacterial infections, particularly infections caused by multidrug-resistant pathogens. He also holds a master’s degree in Biochemistry.  He attended CUNY-City College of New York where he earned an undergraduate degree in Biochemistry, Anthropology, African Studies, and Education. He currently serves as a Research Assistant Professor at the Department of Microbiology and Molecular genetics, University of Pittsburgh School of Medicine. Berthony also attended the Faculté de Médecine de Port-au-Prince for three years prior to moving to the United States. Berthony’s publications include: (2007) De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J Antimicrob Chemother, (2005) Antimicrobial peptides in mucosal secretions: the importance of local secretions in mitigating infection, (2005) De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity, (2005) Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications, (2003) Selective toxicity of engineered lentivirus lytic peptides in a CF airway cell model, and(2003) A heme-deficient strain of Escherichia coli has a three-base pair deletion in a “hotspot” in hemA.

Back to the ALPAM team page

Haiti needs your support

Haiti is tired of surviving only by managing crises. Would you commit to at least $1 per month for transformative changes in Haiti? Thank you for your support!

Our team

  • Indira Denis, BSN, RN

    indira-l-denis

    Director
  • DANIEL DUME-CHARLES, MD

    Daniel Dume-Charles, MD

    Director
  • Celestin Odilon,  Restaurateur

      celestin-odilon-business-owner

    Director
  • Berthony Deslouches, MD, PhD

    Berthony Deslouches, MD, PhD

    Director
  • Marcel Denis, JD, LLM, ESQ.

     Marcel Denis

    Executive Director

Services to be provided

Canteen
Immigration services

Essay submission

Pages

  • About us
  • Berthony Deslouches, MD, PhD
  • Celestin Odilon, Restaurateur
  • Daniel Dume-Charles, MD
  • Essay submission
  • Indira Denis, BSN, RN
  • KOTE KI PA GENYEN SITIRÈ PA KA GENYEN VÒLÈ
  • Marcel Denis, JD, LLM, ESQ.
  • Our mission
  • Our Work
  • Participant
  • Recovery efforts from the devastation of Hurricane Matthew
  • Send us a message, we would love to know what you think
  • The Alpam team
  • The devastation of Haiti by Hurricane Matthew
  • Volunteering
  • Weekly forum April 14, 2017 by ALPAM GROUP
  • Weekly forum April 7, 2017 by ALPAM GROUP
  • Weekly forum March 3, 2017 by ALPAM GROUP
  • Weekly forum March 31, 2017 by ALPAM GROUP

Archives

  • October 2018
  • May 2017
  • April 2017
  • November 2016
  • September 2016

WordPress

  • Log in
  • WordPress
© ALPAM Group, INC